A Controlled Study of the Aqueous Humor Dynamics of AR-13324 Ophthalmic Solution in Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Netarsudil (Primary)
- Indications Glaucoma; Ocular hypertension
- Focus Pharmacodynamics
- Sponsors Aerie Pharmaceuticals
- 13 May 2016 Status changed from active, no longer recruiting to completed.
- 21 Mar 2016 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
- 07 Dec 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov.